https://www.prnewswire.com/news-releases/inspiremd-reports-record-third-quarter-2011-operating-and-financial-results-and-strategic-update-133870008.html
InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update
/PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercialization of...
third quarter
https://www.biospace.com/inspiremd-ltd-announces-the-enrollment-of-the-1st-patient-in-the-mguard-tm-israeli-registry
InspireMD Ltd. Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry -...
https://www.home.saxo/nb-no/markets/stocks/nspr-xnas
InspireMD Inc aksje | Saxo Bank
InspireMD Inc is a United States-based medical device company.
inspiremdincaksjesaxobank
https://www.prnewswire.com/news-releases/inspiremd-is-proud-to-introduce-mguard-primer-inspiremds-new-cobalt-chromium-micronetr-protective-stent-system-103609099.html
InspireMD is Proud to Introduce MGuard Prime(R), InspireMD's new Cobalt Chromium MicroNet(R)...
/PRNewswire/ -- InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT...
https://www.insidermonkey.com/blog/inspiremd-inc-nasdaqnspr-q1-2024-earnings-call-transcript-1303681/
InspireMD, Inc. (NASDAQ:NSPR) Q1 2024 Earnings Call Transcript - Insider Monkey
Operator: Greetings, and welcome to the InspireMD First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
earnings call transcriptq1 2024inspiremdincnasdaq
https://www.prnewswire.com/news-releases/inspiremd-files-at-the-market-offering-and-shelf-registration-statement-229085771.html
InspireMD Files At-the-Market Offering and Shelf Registration Statement
/PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it has filed a...
at the market offeringshelf registrationinspiremdfilesstatement
https://www.macrotrends.net/stocks/charts/NSPR/inspiremd/operating-margin
InspireMD Operating Margin 2013-2025 | NSPR | MacroTrends
Current and historical operating margin for InspireMD (NSPR) over the last 10 years. The current operating profit margin for InspireMD as of December 31, 2025...
operating margininspiremd20132025nspr
https://www.biospace.com/inspiremd-to-report-first-quarter-2023-financial-results-on-may-9-2023-and-provide-corporate-business-update-conference-call-and-webcast-to-be-held-at-8-30-a-m-edt
InspireMD to Report First Quarter 2023 Financial Results on May 9, 2023, and Provide Corporate...
Apr 28, 2023 - InspireMD, Inc. announced it will report first quarter 2023 financial results on Tuesday, May 9th, 2023, before the financial markets open.
https://finviz.com/quote?a=30565236&t=NSPR
NSPR - InspireMD Inc Stock Price and Quote
NSPR - InspireMD Inc - Stock screener for investors and traders, financial visualizations.
stock pricensprinspiremdincquote
https://www.prnewswire.com/news-releases/inspiremd-to-ring-opening-bell-at-new-york-stock-exchange-on-thursday-october-24th-228971621.html
InspireMD to Ring Opening Bell at New York Stock Exchange on Thursday, October 24th
/PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will ring the...
new york stock exchange
https://www.home.saxo/nl-be/markets/stocks/nspr-xnas
InspireMD Inc aandeel | Saxo Bank
InspireMD Inc is a United States-based medical device company.
inspiremdincaandeelsaxobank
https://www.prnewswire.com/news-releases/positive-results-of-inspiremds-master-trial-to-be-published-on-november-6-in-journal-of-american-college-of-cardiology-177238171.html
Positive Results of InspireMD's MASTER Trial to be Published on November 6 in Journal of American...
/PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (OTC: NSPR) announced today that the randomized 432-patient MASTER trial of its embolic...
https://www.prnewswire.com/news-releases/inspiremd-elects-sol-j-barer-phd-chairman-of-the-board-of-directors-134026188.html
InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
/PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercialization of...
chairman of the board
https://www.prnewswire.com/news-releases/inspiremd-reports-financial-results-for-quarter-ended-september-30-2013-231477971.html
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
/PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results for...
financial resultsseptember 30inspiremdreportsquarter
https://stockanalysis.com/stocks/nspr/
InspireMD (NSPR) Stock Price & Overview
A detailed overview of InspireMD, Inc. (NSPR) stock, including real-time price, chart, key statistics, news, and more.
stock priceinspiremdnsproverview
https://robinhood.com/us/en/stocks/NSPRZ/
InspireMD, Inc. Series B Warrants: NSPRZ Stock Price Quote & News | Robinhood
You can watch NSPRZ and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying...
series bstock priceinspiremdincwarrants
https://www.prnewswire.com/news-releases/inspiremd-provides-corporate-update-plans-for-2012-137879793.html
InspireMD Provides Corporate Update, Plans for 2012
/PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of...
corporate updateinspiremdprovidesplans2012